Security Snapshot

SESEN BIO INC - COM (SESN) Institutional Ownership

CUSIP: 817763105

13F Institutional Holders and Ownership History from Q2 2018 to Q2 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SESN - SESEN BIO INC - COM is tracked under CUSIP 817763105.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1 to 0 between Q1 2023 and Q2 2023.
  • SEC-reported value moved from $10,433 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

817763105

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Latest
n/a
Rows shown
1-21 of 21
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$10,433 0
2023 Q1 4,140 $10,433 -$19,785,202 $2.52 1
2022 Q4 32,465,314 $19,785,532 -$819,195 $0.61 64
2022 Q3 25,821,712 $10,972,667 -$1,894,995 $0.42 61
2022 Q2 28,437,618 $23,046,460 -$11,922,830 $0.81 64
2022 Q1 43,807,379 $26,401,422 -$2,838,300 $0.60 74
2021 Q4 47,938,283 $39,065,222 -$1,248,105 $0.82 88
2021 Q3 49,493,166 $39,249,862 -$35,322,911 $0.79 93
2021 Q2 66,216,243 $305,912,458 +$125,959,137 $4.62 104
2021 Q1 40,135,801 $104,353,680 +$46,826,108 $2.60 73
2020 Q4 22,823,124 $30,804,762 +$6,178,836 $1.35 54
2020 Q3 18,222,171 $25,513,754 +$5,966,224 $1.40 42
2020 Q2 13,944,093 $10,035,000 +$1,257,644 $0.72 35
2020 Q1 12,029,326 $6,745,780 -$1,156,645 $0.56 30
2019 Q4 13,184,438 $13,712,000 -$6,208,038 $1.04 41
2019 Q3 18,530,905 $21,678,000 -$7,585,284 $1.17 33
2019 Q2 24,195,130 $36,292,000 +$16,443,601 $1.50 37
2019 Q1 13,876,762 $14,294,630 -$17,053,949 $1.03 40
2018 Q4 25,649,209 $36,420,420 -$16,179,006 $1.42 41
2018 Q3 32,468,390 $69,808,150 -$5,202,815 $2.15 42
2018 Q2 35,258,228 $68,754,950 +$68,754,950 $1.95 44
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .